Quarterly report pursuant to Section 13 or 15(d)

NOTES PAYABLE (Details Narrative)

v3.24.3
NOTES PAYABLE (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 01, 2024
Mar. 06, 2024
Jun. 01, 2023
Jul. 28, 2020
Nov. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                    
Debt Instrument, Unamortized Discount           $ 0   $ 0   $ 2,954,000
Interest Expense, Debt           400,000 $ 1,000,000 1,800,000 $ 2,900,000  
Debt Instrument, Face Amount           0   0   16,304,000
Lenders [Member]                    
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                    
Debt Instrument, Unamortized Discount           3,000,000   3,000,000    
Share-Based Payment Arrangement, Tranche One [Member]                    
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                    
Debt Instrument, Face Amount       $ 20,000,000            
Insurance Policy [Member]                    
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                    
Prepaid expenses           $ 34,600   34,600   $ 300,000
Loan Agreement [Member]                    
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                    
Notes payable         $ 400,000          
Monthly principal and interest payments         $ 39,000          
Monthly loan payments term         10-month period          
Annual interest rate         8.15%          
Loan Agreement [Member] | K2 HealthVentures LLC [Member]                    
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                    
Debt conversion amount   $ 1,100,000 $ 900,000         5,000,000    
Debt conversion per share   $ 7.875 $ 4.5              
Warrants to purchase shares of common stock, exercised   142,857 194,444 2,873            
Warrant exercisable price per share       $ 208.8            
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-Based Payment Arrangement, Tranche One [Member]                    
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                    
Secured debt       $ 20,000,000            
Loan Agreement [Member] | Debt 1a [Member] | K2 HealthVentures LLC [Member] | Minimum [Member]                    
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                    
Debt conversion amount               $ 900,000    
Debt conversion per share           $ 4.5   $ 4.5    
Loan Agreement [Member] | Debt 1b [Member] | K2 HealthVentures LLC [Member]                    
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                    
Debt conversion amount               $ 1,100,000    
Debt conversion per share           7.875   $ 7.875    
Loan Agreement [Member] | Debt 2 [Member] | K2 HealthVentures LLC [Member]                    
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                    
Debt conversion amount               $ 3,000,000    
Debt conversion per share           $ 282   $ 282    
Amended loan agreement [Member]                    
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                    
Final payment $ 1,600,000                  
Loan Maturity Final Amount 11,800,000                  
Debt Instrument Outstanding principal Amount 10,100,000                  
Debt Instrument, Periodic Payment, Interest $ 1,600,000                  
Amended loan agreement [Member] | K2 HealthVentures LLC [Member]                    
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                    
Debt description       Interest payments were made monthly and accrued at a variable annual rate equal to the greater of (i) 8.5% and (ii) the rate of interest noted in The Wall Street Journal, Money Rates section, as the “Prime Rate” plus 5.25%.